Kaytee Bio is a biotech company that research and develop new drugs and diagnostic technologies.



We have presented our latest multi-center research about BiologicMate® for the efficacy of infliximab in  2016 EULAR Congress Meeting in  London (June 8-11th, 2016). Details Here!



Kaytee Bio, Co.&Ltd. was posted on the April issue of Nature’s MedTech Dealmakers which have a journalistic feature on diagnostics.


Kaytee Bio,Co.&Ltd. concluded the License Contracts on the distribution and R&D of our technology regarding  BiologicMate® and Talin Test exclusively in the countries including U.S.A. with Japanese Organization for Medical Device Development, Inc (https://jomdd.com). 



We have presented our latest findings about BiologicMate® in 2014 ACR/ARHP Annual Scientific Meeting (Nov 15th-19th) in Boston.

Kaytee Bio Co.&Ltd.




   Room #505,

   Yamaguchi Bdg,      


   4-38-22,  Honcho,                      


   Chiba 273-0005, JAPAN

   TEL: +81474110017

   FAX: +81474110018